2016
DOI: 10.1111/jop.12523
|View full text |Cite
|
Sign up to set email alerts
|

A loss of profilin‐1 in late‐stage oral squamous cell carcinoma

Abstract: BACKGROUND The genes for PFN1 and TMSB4 are both highly expressed in oral tissue and both encode actin monomer binding proteins thought to play a role in cell motility and possibly other crucial parts of tumor progression. METHODS Oral brush cytology of epithelium from Oral Squamous Cell Carcinoma (OSCC) was used to measure PFN1 and TMSB4 mRNA in OSCC while immunohistochemical analysis of tissue was used to check protein levels. RESULTS High but variable expression of mRNAs encoding these two proteins was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 29 publications
0
3
0
Order By: Relevance
“…Of the genes coding matrix metallopeptidases, differential expression of MMP11 was found as an early event in oral tumor progression 50 , but that of MMP12 could not be associated with oral cancer progression from previous studies. An immunohistochemical analysis of KRT13 had shown a loss of expression in OSCC cells while it was expressed in normal differentiated basal and suprabasal oral mucosa epithelial cells 51 . Thus, KRT13 can also be treated as a biomarker for progression to OSCC-GB.…”
Section: Discussionmentioning
confidence: 99%
“…Of the genes coding matrix metallopeptidases, differential expression of MMP11 was found as an early event in oral tumor progression 50 , but that of MMP12 could not be associated with oral cancer progression from previous studies. An immunohistochemical analysis of KRT13 had shown a loss of expression in OSCC cells while it was expressed in normal differentiated basal and suprabasal oral mucosa epithelial cells 51 . Thus, KRT13 can also be treated as a biomarker for progression to OSCC-GB.…”
Section: Discussionmentioning
confidence: 99%
“…PFN1 has been found to be downregulated in multiple late-stage cancers, including breast, pancreatic, and bladder malignancies . Loss of PFN1 has been preliminarily associated with lymph node metastasis and poorer prognosis in oral cavity cancers, , suggestive of PFN2 as a tumor suppressor, but no association with OPSCC has been identified.…”
Section: Discussionmentioning
confidence: 99%
“…In head and neck squamous cell carcinoma (HNSCC), downregulation of PFN2 reduced phosphorylation/expression of AKT, GSK-3β, and β-catenin, leading to reduced invasion and metastasis [24]. In oral squamous cell carcinoma (OSCC) tissues, PFN1 levels were lower in tumor epithelium and has been associated with lymph node metastasis [25]. In hepatocellular carcinoma profilin was a direct target for miR-19a-3p and low expression of profilin was correlated with poor prognosis in patients [26].…”
Section: Profilin In Cancermentioning
confidence: 99%